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can be replaced with semiautomatic segmentation.
METHODS AND MATERIALS: Semiautomatic segmentation using a tapered ellipsoid model
was applied to transrectal ultrasound images. Region-based volumetric evaluation was performed
between original and physician-reviewed semiautomatic contours. For dosimetric assessment, treat-
ment plans generated on semiautomatic contours were overlaid on physician-reviewed semiautomatic
contours and dose parameters were computed. To establish a threshold for the acceptable amount of
dosimetric degradation below which the adoption of semiautomatic planning is unacceptable, the
range of variability in dosimetric quality attributed to manual variability was obtained and compared
with that of semiautomatic contours.
RESULTS: An average volume error (1dDice similarity coefficient) of less than 7% between semi-
automatic and manual volumes (140 cases) was obtained. The difference between the mean V100 of
plans created for semiautomatic contours then overlaid on physician-reviewed semiautomatic
contours and the original V100 values, that is, before overlaying on the physician-reviewed contours
(41 cases) was lower than 5%.An average total duration of 2e4 min, which includes algorithm initial-
ization, 11.67 3.57 s algorithm time, and contourmodification is required per case. This algorithm is
being used at theBritishColumbiaCancerAgency and to this date has been applied for the treatment of
more than 600 patients.
CONCLUSIONS: In terms of volumetric and dosimetric accuracy, the proposed algorithm is a suit-
able replacement for manual segmentation in the context of our planning technique. The benefits are
shorter segmentation times; greater consistency; less reliance on user experience; and smooth,
symmetric contours.  2013 American Brachytherapy Society. Published by Elsevier Inc. All rights
reserved.Keywords: Prostate segmentation; Dosimetric evaluation; Prostate brachytherapyIntroduction
Accurate, consistent delineation of the prostate boundary
is important for effective treatment of prostate cancer with
radiation therapy and applies to both external beam therapy011; received in revised form 5 July 2011; accepted
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nt matter  2013 American Brachytherapy Society. Publis
.1016/j.brachy.2011.07.007and brachytherapy. For transperineal brachytherapy, this is
usually done by manual segmentation of transverse B-mode
images derived from transrectal ultrasound (TRUS) imaging.
Although it is a safe and real-time system, TRUS does not
provide an unambiguous image of the gland, thus affecting
themanual delineation of the prostate. Various attempts have
been made to improve prostate visibility. Daanen et al. (1)
attempted to fuseMRI data with TRUS data for more reliable
image processing and prostate volume identification.
However, MRI is not part of the standard of care for prostate
radiation treatment and would add expense and time to the
treatment. Furthermore, because TRUS and MRI are carried
out under different conditions (different rectum deformation
by endorectal coils or TRUS and different leg and pelvished by Elsevier Inc. All rights reserved.
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be used. In previous reports by Sahba et al. (2) and Pathak
et al. (3), image processing techniques have been used for
ultrasound image enhancement.
Different imaging modalities lead to different segmenta-
tion results. For example, Smith et al. (4) have evaluated
the reproducibility and modality differences of prostate
contouring, after brachytherapy implants, using three-
dimensional (3D) TRUS and T2-weighted MR and CT
imaging. Prostates from 10 patients with early-stage pros-
tate cancer (T2b or less) were segmented twice by seven
observers. Their results showed high contouring variability
of the anterior base and apex in 3DTRUS, whereas the
prostateerectum interface had the smallest variability. In
TRUS imaging, the interobserver variability of prostate
contouring is high. A study by Choi et al. (5) showed that
prostate volume measurement by TRUS may vary among
observers when patients have large prostates ($30 cm3).
The average volume difference between 101 prostates
measured by two experienced observers was reported as
6.00 cm3 for prostates with a mean measured volume of
30 cm3 or more and 1.51 cm3 for prostates with a mean
measured volume of 30 cm3 or less. These numbers
increased to 6.84 cm3 and 3.99 cm3, respectively, when
measurements were performed by one experienced and
one less experienced observer (110 prostate volumes
measured in this case).
In low-dose rate (LDR) permanent implant brachyther-
apy, for ease of planning and more robust seed implanta-
tion, some centers prefer contours that are smooth and
symmetric with respect to the medial line (6) in the trans-
verse plane. These two requirements are difficult to satisfy
manually, whereas an automatic segmentation method, in
addition to producing a smooth and symmetric volume,
can reduce the variability of the contours related to the
observer bias and random factors. Additionally, the time
required for performing segmentation can be greatly
reduced, and thus can be adapted for subsequent intraoper-
ative planning.
Various ultrasound-based segmentation methods have
been proposed in the literature. Methods using higher-
level knowledge, such as using 3D geometric shapes, in
addition to lower-level image information, such as texture
and edges, have been more successful compared with pure
image-based segmentation methods. Deformable models
(such as active contour models or snakes) are surfaces
or curves that deform based on various parameters, such
as the amount of curvature and image intensity gradients.
Examples and different variations of these methods are
presented in the literature (7, 8). These models create
continuous contours, which may get trapped by false
edges. Statistical shape models (9, 10) or active shape
models incorporate statistically extracted variations in
the shape. Their deformation toward the boundary of an
object is constrained by the characteristics of the object
they represent.The anatomy of the prostate suggests fitting ellipses,
ellipsoids, superellipses, and similar geometries. In deform-
able superellipses (11), ellipses with additional squareness,
tapering, and bending parameters are used. Their automatic
segmentation results on 125 prostate ultrasound images
showed a mean error of less than 2 mm between
computer-generated and manual contours. However, their
method generated 2D segmentation of the prostate, which
may suffer from the inability to segment low quality images,
especially at the base and apex. By comparison, a 3D
segmentation algorithm can produce contours even for the
poor images at the prostate’s superior (anterior base) and
inferior (apical) zones by using the higher quality midgland
images. Furthermore, in 3D segmentation, axial continuity
is easily maintained. This is achieved during manual
segmentation by visually comparing contours of various
image depths. The 3D segmentation method provided in
the literature (12) requires 90 s to create the prostate surface
model and generate the solid models necessary for high-
intensity focused ultrasound therapy planning. Manual
tracing of approximately five transverse and three sagittal
images of the prostate is needed to initialize this algorithm.
This adds to the total segmentation duration and introduces
an observer variability that has not been quantified.
Other 3D methods have been proposed in the literature
(9, 10, 13). These methods either require extensive user
interaction (e.g., manual delineation of several images for
initialization of the algorithm) or require a long processing
time or modifications to the conventional imaging system.
Moreover, rarely has the intra- and interobserver variability
of the resulting contours been evaluated and compared with
that of manual contouring (12, 13).
The ellipsoid fitting method in the report by Badiei
et al. (14) is fast and produces symmetric and smooth
3D volumes. This method assumes an ellipsoidal shape
of the prostate anatomy, whereas tapering is usually
observed in both the transverse plane and along the main
axis of the prostate. We have gradually resolved this
problem in our earlier work (15, 16) to produce a 3D
semiautomatic segmentation method. Compared with the
above-mentioned methods, this algorithm is fast and has
been shown to generate reliable and repeatable clinical
target volumes (CTVs), making it a suitable candidate
for real-time use in brachytherapy treatment planning
and dosimetric evaluation.
In this article, we provide an extensive clinical validation
of the segmentation method from our earlier work (17),
which is being used as a part of the LDR prostate brachyther-
apy procedure at the Vancouver Cancer Center and BC
Cancer Agency (BCCA). Currently, the semiautomatic
contour is first approved and modified, if required, before
treatment planning. The results from our earlier work (17)
suggested that such modifications are so minor that they
may not be necessary in many cases. Indeed, a volumetric
study showed that the semiautomatic segmentation error is
within the range of inter- and intraobserver variability of
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suggests that on average, no greater variation is introduced
by using the algorithm than would be expected if a different
oncologist performed the contour. The aim of this article is to
extend the volumetric analysis conducted in our earlier
work (17) to a larger data set and to show that the segmenta-
tion error leads to a dose error that is negligible.Methods and materials
The segmentation algorithm
For the sake of readability and completeness, we will
provide a summary of the segmentation algorithm from our
earlier report (17). As per the BCCA protocol, the contouring
algorithm assumes that a smooth and symmetric CTV is the
aim of the oncologist, who consequently positions the pros-
tate symmetrically across the midsagittal plane during TRUS
image acquisition. The use of symmetric contours for treat-
ment planning is widely practiced as part of the popular Se-
attle preplanning technique (6). Symmetric contours lead to
simple treatment plans that are also simple to change to
ensure adequate dose coverage should the shape, size, or
position of the prostate change significantly with respect to
the volume study. By maintaining symmetry during the
preoperative volume study, reproducing the prostate image
intraoperatively is relatively simple because the body’s long
axis can be identified easily in the dorsolithotomy position
and does not change over time or in response to shifting leg
positions and tissue relaxation. However, replicating
a specific arrangement of misalignment is not easily accom-
plished because there are numerousways tomisalign the axes
of the TRUS probe and of the prostate, each of which creates
a somewhat different visual pattern of asymmetry on the
TRUS images. We emphasize the need to maintain proper
body alignment throughout both the TRUS image acquisition
and intraoperatively because, in most cases, maintaining this
is sufficient to achieve symmetry on all slices. Effective
implementation of a symmetric planning approach is demon-
strated by our 2009 population-based report with only
35 recurrence events among the first 1006 consecutiveBCCAFig. 1. Illustration of the main steps of the TES segmentation algorithm. (a) Init
untapered image; (c) Propagation of two-dimensional segmentation to the other sli
depths and tapering and warping the resulting contours. IMMPDA5 interactingprostate brachytherapy patients who underwent implant
between July 1998 and October 2003 (18).
The basic premise of the contouring algorithm is that by
applying a series of transforms to the ultrasound data, the
prostate is rendered to be approximately elliptical, which
makes a subsequent 3D fitting procedure more computa-
tionally efficient and the results more robust. The idea of
fitting warped ellipses to the TRUS images and a final
warped ellipsoid to the resulting contours in a report by
Badiei et al. (14) is extended to fitting tapered and warped
ellipses and a tapered and warped ellipsoid to obtain better
fitting contours. The posterior warping is required to
account for the posterior deformation of the gland caused
by the presence of the ultrasound probe and the tapering
parameter is added for better agreement with the anatomy
of the prostate. Because fitting such 2D and 3D shapes to
the TRUS images may be computationally expensive, the
TRUS images themselves are deformed to result in ellip-
tical cross-sections of the gland. Fitting an ellipse is a fast
and straightforward problem. Figure 1 shows the main steps
of the semiautomatic segmentation algorithm.
The algorithm is initiated by the user identifying the base,
apex, and midgland images; the TRUS probe center; and six
boundary points on the midgland image. The base and apex
images are images in which the most superior and inferior
portions of the prostate are visible. The six boundary points
include: p15 lowest lateral; p25 lateral right; p35midpos-
terior; p45midanterior; and two points, p5 and p6, guided by
points p1, p2, and p4. These points are selected to extract the
size, amount of warping, and the transverse tapering of the
prostate boundary while eliminating the variability of point
selection by directing the user to specific regions (Fig. 1a).
By knowing the location of the TRUS center and the lowest
lateral and midposterior points, all TRUS images are un-
warped to remove the posterior deformation. A tapered
ellipse is then fitted to the initial points and their reflections
with respect to the medial line. The resulting tapering value,
0 # t # 1 (t5 0 being an ellipse), is used to untaper the
TRUS images in the transverse plane. It is assumed that
tapering linearly reduces to zero toward the base and apex,
with these two regions having elliptical cross-sections. Theialization; (b) IMMPDA edge detection (dashed line) on the unwarped and
ces; (d) Tapered ellipsoid fitting, three-dimensional surface slicing at image
multiple model probabilistic data association.
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tapered ellipse contour in the midgland slice to obtain an
initial elliptical contour on this slice. The interactingmultiple
model probabilistic data association (IMMPDA) edge detec-
tion algorithm introduced by Abolmaesumi and Sirouspour
(19) is then used to search for the boundary of the prostate
within a neighborhood of less than 0.5 cm inside and outside
the initial midgland ellipse (Fig. 1b). In effect, the IMMPDA
algorithm acts to leverage a coarse set of manually selected
points to guide a higher resolution detection of the prostate
boundary using statistical sampling techniques designed to
suppress the type of image noise typically found in ultrasound
images. However, because the boundary detected by this
process is neither smooth nor symmetric, a second ellipse is
fitted to form the updated estimation of the prostate contours.
The next step is to propagate this contour from the midg-
land to the remaining slices (Fig. 1c). To do so, two ellip-
soids are fitted to the midgland contour, one to act as
a guide for the volume superior to the midgland and one
for the volume inferior. These ellipsoids are uniquely
defined by the midgland ellipse and the intersection of
the longitudinal axis of the prostate passing through the
center of the midgland contour and the base-1 (one slice
superior to the base slice) and apex þ 1 (one slice inferior
to the apex) slices. The intersection of these ellipsoids with
the image slices create elliptical contours, which are used
as the initial estimates of the prostate boundary on those sli-
ces. These contours, similar to what was done in the midg-
land image, serve as a guide to the IMMPDA edge
detection algorithm to obtain image-based elliptical
contours for each image slice. To ensure smoothness in
the axial direction (i.e., from one slice to the next), a tapered
ellipsoid is fitted to the contours of all images. This shape
has an elliptical cross-section with tapering along its longi-
tudinal axis. Finally, the 3D volume is sliced at image
depths and the elliptical contours are tapered and warped
using the initial values to match the original images
(Fig. 1d). Further details and mathematical equations of
the algorithm can be found in our earlier reports (16, 17).
We will hereafter refer to the algorithm and the resulting
contours as the ‘‘tapered ellipsoid segmentation (TES)
algorithm’’ and ‘‘TES contours.’’ Figure 2 shows a snapshot
of the graphical user interface used in the VCC for prostate
contouring using the TES method. This algorithm has been
routinely used to support clinical treatment planning at
VCC since January 2009 and to this date more than 600
cases have been planned using our proposed method.Patient characteristics and treatment planning
LDR brachytherapy is indicated at the BCCA for low-
and intermediate-risk prostate cancer (all of: pretreatment
prostate-specific antigen level #20, Gleason score #7,
clinical stage #T2c [International Union Against Cancer
(UICC) 1997]). Three to four weeks before the implant,
a radiation oncologist (RO) performs a volume study inwhich 2D ultrasound images are obtained at 5 mm intervals
with the use of a transrectal ultrasound probe (B&K
Pro-Focus System B-series ultrasound machine; BK
Medical, Peabody, MA, with the MFI Biplane Transducer,
640 480 pixels image size, 0.15 mm 0.15 mm pixel
size). The patient is in the dorsal lithotomy position during
imaging. For applying the TES algorithm on these clinical
images, appropriate institutional and ethics committee
approval have been obtained. The TES algorithm is initi-
ated by a radiation therapist to produce a CTV called the
‘‘Raw TES CTV.’’ The contours are then transferred to
the treatment planning system (VariSeed; Varian Medical
Systems, Palo Alto, CA) where they are modified if neces-
sary and then approved for planning by a RO. This volume
will be referred to as the ‘‘RO-reviewed TES CTV,’’ which
is used to produce the planning target volume (PTV). For
the purposes of comparing the dosimetric effect of the
RO modifications, a second PTV was also generated
directly from the Raw TES CTV, which will be referred
to as the ‘‘Raw TES PTV.’’ The guidelines for the creation
of the PTV at this institution recommend applying
0.3e0.5 cm lateral, 0e0.3 cm anterior, and 0.5 cm superior
margins to the CTV. No planning margins are added poste-
riorly or inferiorly to spare the rectum and penile bulb.
Although small variations in the size of the margins were
present among clinically generated PTVs, the margins
applied to generate the Raw TES PTVs for this study
complied with the guideline recommendations (0.3 cm
lateral, 0.2 cm anterior, and 0.5 cm superior).
An additional component of this study involved the use of
contours that were generated completely manually (i.e.,
without the presence of any preliminary contours on the image
sets) by multiple blinded observers (ROs, radiation therapists,
and/or individuals trained by experts). We will describe these
contours and their derivative structures as ‘‘manually’’ gener-
ated to distinguish them from the ‘‘RO-reviewed TES’’
contours, which are informed by the TES algorithm.
Brachytherapy treatment plans were developed for the
PTVs by a single medical physicist. These plans adhered
to the standard BCCA planning algorithm, which can be
generally described as following a low-activity (0.424 U)
modified peripheral loading strategy using custom-loaded,
stranded seeds (RAPIDStrand; Oncura, Arlington Heights,
IL). Each plan is designed to provide 97% or higher
coverage of the PTV and 99% or higher coverage of the
CTV by the 100% (144 Gy) isodose, with a CTV V150
between 56% and 65% and PTV V150 between 50% and
60%. The V150 is geometrically biased to the posterolateral
aspects of the target. The volume that does not reach
prescription dose in planning is confined to a small region
of the anterior base of the PTV whenever possible.Evaluation measures
To evaluate the TES method, two types of comparisons
were carried out: volumetric and dosimetric. The volumetric
Fig. 2. A snapshot of the graphical user interface for automatic prostate segmentation used at the Vancouver Cancer Center.
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between Raw TES and RO-reviewed TES contours. The
dosimetric comparisons were designed to investigate what
the impact on coverage of the RO-reviewed PTVwould have
been if planning had been performed directly on theRawTES
PTV. To do this, treatment plans were originally created on
Raw TES contours, while satisfying the BCCA planning
goals, and subsequently superimposed on the corresponding
RO-reviewed TES contours. Plans derived from Raw TES
PTVs were also compared with the plans created on the
manual contours of different observers on the same image
set. Details of each of the evaluation methods are described
in the next section.
We will first define the evaluation measures used in this
article. These measures were calculated for nine sectors of
the prostate (Fig. 3). These sectors were created by dividing
the CTV (for volumetric analysis) or PTV (for dosimetric
analysis) into superior, midgland, and inferior sections,
respectively (0.3 cm, 0.4 cm, and 0.3 cm of the baseeapex
length of the CTV or PTV), which were then partitioned
into posterior, anterior, or lateral portions of the gland.
The motivation behind such a division was to identifywhether there was a region-specific variability in the
results, given that there may be different consequences to
treatment from segmentation errors in different regions of
the implantation volume (20, 21). For example, overcon-
touring the posterior region of the gland may increase the
risk of severe rectal complications. A similar sector-based
study was performed by Bice et al. (22) for a more local-
ized doseevolume histogram analysis of postimplant dose
distributions.
Volumetric measures
The four volumetric comparison measures, which we
described in our earlier reports (17) are summarized in
Table 1 and illustrated in Fig. 4.
For evaluation of the dose distribution, the following
parameters were computed.
The standard dose paramter, V100
The volume of the PTV receiving 100% or more of the
prescribed dose, was computed for the nine sectors of the
PTV and the whole PTV. These values were calculated by
the VariSeed software.
Fig. 3. Dividing the prostate into nine sectors. (a) Whole volume; (b) transverse view. Ant.5 anterior; Lat.5 lateral; Post.5 posterior.
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To characterize extraprostatic dose, the external index
(EI) (24), defined in Eq. 5, measures the amount of tissue
external to the PTV that receives doses of 150% or more
of the prescribed dose.EI1505 ð isoV150  V150 Þ = V ð5Þ
isoV150 is the total volume of the 150% isodose surface,
V150 is the volume of the PTV receiving 150% or more of
the prescribed dose (the volume of the intersection between
the isoV150 and PTV surfaces) and V is the volume of the
PTV. Ideally, EI150 is zero.
The conformity index 100, CI100
A 3D extension of the conformity index (CI) defined by
Otto and Clark (25) is used, which measures both the
undercoverage of the target as well as the overtreatment
of the normal tissues.CI100 %5 100 volume of region ðvolume of region underdoseþ volume of healthy tissue doseÞvolume of region ð6ÞIn Eq. 6, volume of region is the volume of the PTV
(or one of its nine sectors), volume of region underdose is
the volume of the PTV (or one of its nine sectors) that is
receiving less than 100% of the prescribed dose, and
volume of healthy tissue dose is the volume of the region
outside the PTV (or one of its nine sectors) that is receiving
100% or more of the prescribed dose. A maximum confor-
mity value of 1 shows perfect conformity of the 100%
isodose to the region being observed.
We would like to note that although the above-
mentioned dose parameters are computed to evaluate the
TES method, our planning process places quantitative
constraints only on the whole prostate and whole PTV
and CTV V100 and V150. Regional PTV coverage by the100% isodose, location and shape of the 150% isodose,
and the extent of extraprostatic dose are evaluated and con-
strained on the basis of visual (qualitative) inspection of the
isodose distributions, rather than by adherence to regional
constraints on V100 or CI100. Consequently, in this study,
we assess dosimetric differences from the observed clinical
baselines in each region rather than from absolute values.Volumetric evaluation of the algorithm
In this analysis, the four volumetric measures of agree-
ment (see Table 1) between the Raw TES CTVs (created
by radiation therapists) and the RO-reviewed TES CTVs
were computed for 140 randomly selected retrospective
cases (40 cases seen between January 2009 and April
2009 and 100 cases seen between January 2010 and
September 2010). This analysis indicates how satisfied
the physicians were with the results of the algorithm andwhich regions required the most modifications. We refer
the readers to our earlier work (17) for a comparison of the
above volumetric evaluation (on 40 cases) with inter- and
intraobserver variability in manual contouring.Dosimetric evaluation of the algorithm
Impact of planning using TES contours
The aim of the dosimetric evaluation is to examine the
clinical impact of planning using Raw TES contours. This
helps to put differences in volumetric coincidence in
perspective because if such differences do not result in
a significant degradation in dosimetry when a Raw TES-
derived plan is used to treat a reference contour, then it is
Table 1
The volumetric measures used in this article
Volumetric measure and definition Equation
Percent volume error: the percentage of nonoverlapping volume
between the prostate CTVs (or sectors).
Verr5100 ðVA þVB  2ðVAXBÞÞ=ðVA þVBÞ
½equivalent to ‘1-Dice similarity coefficient’ ð23Þ
ð1Þ
Percent volume difference: the difference between the volumes of
two prostate CTVs (or sectors), with respect to volume B.
Vdiff 5100 ðVA VBÞ=ðVBÞ ð2Þ
Mean Absolute Distance, MAD: the average absolute radial
distance between two CTV contours CA and CB.
MAD5
1
N
XN
i51
jdrij;N5360 ð3Þ
Maximum Distance, MaxD: the maximum absolute radial
distance between contours CA and CB.
MaxD5maxfjdrij: i51;.;Ng ð4Þ
CTV5 clinical target volume.
Verr and Vdiff describe the similarity in the shape and similarity in the size of the two prostate surfaces, respectively. MAD andMaxD are computed for the
midgland slices only, where the prostate boundary is generally the most visible.
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are of equivalent utility for planning purposes.
To investigate this, 41 anonymized consecutive patients
(seen between January 2009 and April 2009) had treatment
plans generated using their Raw TES PTVs as described in
the ‘‘Patient characteristics and treatment planning’’
section. The aforementioned dose parameters for these
plans were calculated for the PTV and the nine sectors
and used as the observed clinical baselines. These plans
were then overlaid on the reference (RO-reviewed TES)
contours and the resulting dose parameters calculated for
the PTV and the nine sectors. The distribution of paired
differences in the dose parameters was calculated (i.e., dose
parameter of the plan generated using Raw TES PTVs and
overlaid on RO-reviewed TES PTVs minus the observed
clinical baseline values).
The effect of contour variability on planning
Although the impact of TES-based planning is readily
calculated, establishing a sensible threshold for the acceptable
amountof dosimetric degradationbelowwhich the adoptionof
TES-based planning is unacceptable is challenging. For
example, a plan with a whole PTV V100 below 97% wouldFig. 4. An illustration of the volumetric comparison measures used in this pape
A and B, and their nonoverlapping volumes; (b) the radial distance between twonot be accepted for implant at our institution, so it may seem
natural to set this as a target for TES-based planning.However,
the patient might have been seen by any number of oncolo-
gists, none of whose plans are explicitly required to meet the
97% criterion on the contours of their colleagues. To avoid
a double standard, the evaluation of any automatic contouring
algorithm cannot ignore the implicitly accepted differences in
dosimetry, which arise from the endemic variability in target
definition between observers. Consequently, TES-based plan-
ning in this study is evaluated in this context, by elucidating the
range of variability in dosimetric quality that is entirely attrib-
utable tomanual interobserver variability, and then examining
how the impact of TES-based planning compares with this
range. This is performed in two tests. First, in a subset of 5
(of the 41) cases, the treatment plan produced on the set of
contours originally used in the patient’s treatmentwas overlaid
on the contours of all 10 observers (all ROs)with the exception
of the implantingRO. In the second test, in one of the 41 cases,
the set of plans produced on the 10 observers’ PTVs are map-
ped back on to the original planning PTV. In all of these tests,
the observers were ROs, blinded to their colleagues’ contours.
In this study, we argue that if TES-based plans fall within the
range of manual variability, it is reasonable to conclude thatr. (a) A two-dimensional representation of two three-dimensional surfaces,
contours CA and CB is shown.
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sense, as planning on the contours drawn by a colleague.Results
Performance
The duration of the TES algorithm per case from when
the initial points are selected until the final contours are
created is 11.67 3.57 s (mean and standard deviation on
140 cases) on a standard PC (Intel Xeon CPU, Intel, Santa
Clara, CA; 2.27 GHz, 3.23 GB RAM). The initialization of
the algorithm (selection of the midgland image and 7 initial
points) requires 30 21 s and an average modification time
of 1e3 min is reported by the physicians using this algo-
rithm. Thus, based on the above, a total segmentation dura-
tion of 2e4 min is expected for each case. Such results
suggest the possibility of using the proposed contouring
method intraoperatively.
Volumetric resultsdcoincidence
Table 2 shows the percent volume error and volume
difference between Raw TES CTVs and RO-reviewed
TES CTVs over 140 cases for each of the nine sectors
and the whole gland. An approximate schematic summa-
rizing the trends in the changes made by the physicians
to the Raw TES CTVs to obtain the RO-reviewed CTVs
is drawn in Fig. 5. The coronal view shows that the midlat-
eral and apical sectors tend to be slightly overestimated by
the segmentation algorithm, whereas the base is slightly
underestimated. The location of the underestimation and
overestimation on the sagittal view suggests that some of
the error may be because of a tilting of the prostate fromTable 2
Comparison between Raw vs. RO-reviewed TES CTV’s
(a) Verr%, percent volume error (mean, 95% confidence interval)
Sector Base Midgland Apex
Anterior 7.8, 1.3 5.1, 0.8 10.1, 1.6
Lateral 6.4, 0.8 4.8, 0.7 10.2, 1.4
Posterior 10.7, 1.5 4.2, 0.6 10.2, 1.9
Total 6.4, 0.6
(b) Vdiff %, percent volume difference (mean, 95% confidence interval)
Sector Base Midgland Apex
Anterior 4.3, 3.3 4.9, 2.2 11.3, 5.3
Lateral 3.3, 2.1 4.5, 2.0 14.0, 4.4
Posterior 16.0, 2.6 3.2, 1.5 5.0, 4.7
Total 1.2, 1.5
RO5 radiation oncologist; TES5 tapered ellipsoid segmentation;
CTV5 clinical target volume.
The means and 95% confidence intervals of the volume error (a) and
volume difference (b) between these two surfaces are calculated for nine
sectors and the whole CTV of 140 cases. Negative values of Vdiff indicate
a larger RO-reviewed TES CTV compared with Raw TES CTV.the superioreinferior axis that has not been perfectly
detected by the algorithm.
The mean and 95% confidence interval for the mean
absolute distance and maximum distance between Raw
and RO-reviewed TES CTVs on the midgland slice is
0.69 mm, 0.10 mm and 0.05 mm, 0.40 mm (140 cases) with
51 of the 140 midgland contours (36%) requiring less than
0.5 mm modification and 113 (81%) requiring less than
1 mm modification.Dosimetric results
Figures 6 and 7 display the paired differences in the V100
and CI100 when the plans created on the Raw TES PTVs are
mapped to the RO-reviewed TES PTVs. In both figures,
each data point represents the difference in the respective
dose parameters for each of the 41 cases, for each sector
of the gland, as well as the whole PTV. Overlaid on the
raw data are the means and 95% confidence intervals.
Where this interval does not include zero, the impact is
considered to be statistically significant, and the corre-
sponding p-value is displayed for each region. The greatest
impact on V100 was seen in the anterior base, anterior apex,
posterior base, and posterior apex. In all regions except the
anterior base and apex, a statistically significant decrease in
V100 was found (p!0.05). For the whole gland, the mean
PTV V100 fell from 98.62 0.12% (observed clinical base-
line) to 96.45 0.70% when the Raw TES derived plans
were applied to the RO-reviewed TES contours.
With respect to CI100, variability in the CI100 was most
pronounced in the apex and lowest in the midgland. The
greatest mean decrease was observed in the anterior apex,
which is consistent with the volumetric analysis establish-
ing a tendency of TES to overcontour this region (see
Table 2). However, in neither this nor any other region
was there a statistically significant impact on the CI100
( pO0.05). For the PTV as a whole, the mean CI100 of
0.68 0.02 fell to only 0.66 0.3 when the Raw TES-
derived plans were mapped to the RO-reviewed contours.
The mean and 95% confidence interval of the PTV
150% isodose external index EI150 (data not shown)
increased from 0.065 0.004 (range, 0.037e0.109) to
0.072 0.010 (range, 0.025e0.160), a statistically insignif-
icant increase in extratarget dose ( p5 0.22). The most
significant increases ( p!0.05) in the EI150 were in the
midanterior (0.01 0.004 to 0.02 0.01, p5 0.03) and
lateral apex (0.21 0.02 to 0.27 0.06, p5 0.04).
However, significant decrease ( p!0.05) in the extratarget
dose was observed in the lateral base (0.18 0.02 to
0.15 0.02, p5 0.00) and posterior base (0.10 0.01 to
0.07 0.01, p5 0.000). No significant changes were
observed in other regions.
The planning goals in our center require a CTV V100 of
99% or greater and a CTV V150 between 56% and 65%. Of
the 41 cases, 11 (27%) had a CTV V100 less than 99%, 3 of
which were less than 98% (96.0%, 97.8%, and 97.3%). In 6
Fig. 5. Schematic of the changes made by the physician to the Raw TES CTVs. Ant.5 anterior; Lat.5 lateral; Post.5 posterior; TES5 tapered ellipsoid
segmentation; CTV5 clinical target volume; RO5 radiation oncologist.
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(range, 50.3e55.9%).
Substantial variability in dosimetric coverage and
conformity arising from manual variability in target delin-
eation is evident in Figs. 8 and 9, which look at the V100
and CI100 parameters, respectively. The subfigures in each
case indicate whether the reference plan was (1) mapped
to other observers’ PTVs or (2) other observers’ plans were
mapped back to a reference PTV. The reference PTV and
plan were those of the oncologist who treated the patient.Fig. 6. Plot illustrates the means and 95% confidence intervals of the
paired difference in the V100 when the treatment plans generated based
on Raw TES PTVs are overlaid on RO-reviewed TES PTVs (i.e., V100
of the plan generated on Raw TES PTVs with respect to the Raw TES
PTVs, the observed clinical baselines, subtracted from V100 of the plan
generated on Raw TES PTVs with respect to the RO-reviewed TES PTVs).
A negative result indicates a decrease in V100. Each column of data repre-
sents a particular region, labeled at the bottom. Each data point represents
the result of 1 of the 41 cases analyzed. The p-values for a null-hypothesis
of no effect in each region are presented at the top of the figure. Two data
points fall outside the range of this figure and are indicated by ‘‘þ1.’’ Their
values are 46.5% (anterior base) and 50.4% (posterior apex). A statistically
significant reduction in V100 is evident in most regions, although the mean
magnitude of the reduction is less than 5%. Ant.5 anterior; Lat.5 lateral;
Post.5 posterior; TES5 tapered ellipsoid segmentation; PTV5 planning
target volume; RO5 radiation oncologist.For the test in which there was a reference plan, the figures
show the mean and 95% confidence intervals of the dose
parameter resulting from the application of the reference
plan to each of the 10 alternate contours produced by the
other observers. This was repeated for five cases, and
a mean and interval is shown for each of these cases, for
each region of the gland. For the test in which there was
a reference PTV, only one of these five cases was analyzed
(the second of the five cases shown in Figs. 8a and 9a), and
so only a single interval is shown in each region. The rawFig. 7. Plot illustrates the means and 95% confidence intervals of the
paired difference in the CI100 when the treatment plans generated for
Raw TES PTV’s are overlaid on RO-reviewed TES PTVs (i.e., CI100 of
the plans created on Raw TES PTVs with respect to the Raw TES PTVs,
the observed clinical baselines, subtracted from the CI100 of plans created
on Raw TES PTVs and overlaid on RO-reviewed TES PTVs). Each
column of data represents a particular region, labeled at the bottom. Each
data point represents the result of 1 of the 41 cases analyzed. A negative
value result indicates a CI100 less than that of the observed clinical base-
line. The number of data points falling outside the displayed range in each
region are indicated. The range of values for these four sectors: Ant. B,
Ant. A, Lat. A, and Post. A, are: [1.70, 0.73], [2.32, 1.36], [2.10,
0.61], and [1.24, 1.49]. The lateral base and posterior base exhibit a statis-
tically significant increase in conformity. Ant.5 anterior; Lat.5 lateral;
Post.5 posterior; TES5 tapered ellipsoid segmentation; PTV5 planning
target volume; RO5 radiation oncologist; CI1005 conformity index 100.
Fig. 8. The means and 95% confidence intervals of the V100 when
(a) a reference plan, created for one set of contours, is overlaid on the
manual contours of 10 other observers in 5 patients, and when (b) a refer-
ence PTV is overlaid on the treatment plans created for the manual
contours of 10 radiation oncologists, for a single patient (second of the
5 patients in [a]). The typical V100 goal of 97% is shown as a dashed hori-
zontal line. For comparison, the results of performing the test using the
TES contours or their derived plans are displayed using the ‘‘:’’ symbols.
Ant.5 anterior; Lat.5 lateral; Post.5 posterior; TES5 tapered ellipsoid
segmentation; PTV5 planning target volume.
Fig. 9. The means and 95% confidence intervals of the CI100 when
(a) a reference plan, created for one set of contours, is overlaid on the
manual contours of 10 other observers in 5 patients, and when (b) a refer-
ence PTV is overlaid on the treatment plans created for the manual
contours of 10 radiation oncologists, for a single patient (second of the
5 patients in [a]). For comparison, the results of performing the test using
the TES contours or their derived plans are displayed using the ‘‘:’’
symbols. Ant.5 anterior; Lat.5 lateral; Post.5 posterior; TES5 tapered
ellipsoid segmentation; PTV5 planning target volume; CI1005 conform-
ity index 100.
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contours are hidden to highlight the relationship between
the special case (marked by the ‘‘:’’ symbol) in which
the test involved the Raw TES PTVor its derived plan, with
the distribution of manual variability (i.e., using the Raw
TES PTV or its derived plan instead of the manual PTV
or its derived plan, in each test).
Extensive interobserver and intercase variability of the
V100 in the anterior base, anterior apex, posterior base,
and posterior apex and of the CI100 in the apex is notice-
able. It is clear from the figures that in most of the exam-
ined situations, the impact on dosimetric quality resulting
from using the TES algorithm is indistinguishable fromthe mean impact expected when using another observer’s
contours. In many cases where the impact is not within this
range, the degradation is less pronounced when using TES
contours than its manual alternatives.
A one-way analysis of variance test confirmed that in
most regions of the prostate in the test of a reference plan
(Figs. 8a and 9a), the dose distribution accuracy of the
plans created on Raw TES PTVs, in terms of the V100
parameter, was better than, or indistinguishable from, that
of the manual distribution. The exceptions are in the ante-
rior base and anterior midregions in three of the five cases
( p!0.05). In terms of the CI100, the TES results are supe-
rior in almost all regions of the prostate for all five cases
75S.S. Mahdavi et al. / Brachytherapy 12 (2013) 65e76( p!0.05) with the exceptions of the anterior base in two
cases and the midposterior and posterior apex sectors in
another. For the tests in which there was a reference PTV
(Figs. 8b and 9b), most TES results are either superior to
or fall within the manual variability of the manual results.
The exceptions are in the anterior base for the V100 and
in the anterior base and midposterior sectors for the CI100.
It is clear from the figures that the dose parameters
computed from overlaying the reference treatment plan
on contours from different observers greatly differs from
overlaying their plans on the reference treatment contour
(compare Figs. 8b and 9b with the second of the five cases
in Figs. 8a and 9a). For this case, the V100 values in Fig. 8b
are in general less than those in Fig. 8a. However, the oppo-
site is observed for the CI100 values in Fig. 9. This was ex-
pected because the RO who created the reference treatment
plan for this case tends to create larger PTV’s. Thus, the
plans created on the other ROs’ contours cannot completely
cover the reference treatment PTV resulting in lower V100
coverage. However, the reference plan created on the rela-
tively large PTV, when overlaid on other ROs’ manual
contours, will result in overdose. This is confirmed by more
regions having negative CI100 values in Fig. 9a. Therefore,
it is important to consider the dynamics of both parameters
in evaluating impact, especially if only one of the above
two tests are performed. Looking at V100 in isolation
obscures, the inherent bias toward overtreatment, as a plan
generated for a high volume target is more likely to encom-
pass the volumes of other observers and result in good
coverage.Discussion and conclusions
In this article, we presented a volumetric and dosimetric
evaluation of our semiautomatic prostate segmentation
algorithm (TES) for ultrasound images (17). In the volu-
metric evaluation, our results on 140 cases showed that
an average whole gland volume error of less than 7% exists
between surfaces created from Raw TES CTV’s and RO-
reviewed TES CTV’s. This value is less in the midgland,
as expected, where the prostate boundary is more visible,
and is higher in the apex.
In the dosimetric evaluation (41 cases), we measured the
difference between the V100 and CI100 dose parameters of
treatment plans created for the Raw TES PTV, used as
the baseline, and treatment plans created for the Raw
TES PTV’s but overlaid on RO-reviewed TES PTV’s.
The mean decrease in V100 and CI100 was less than 5%
and 0.2, respectively, in all regions of the gland. The great-
est degradation in quality occurred in the posterior base and
apex, and anterior base and apex for the V100, and in the
apex for the CI100. However, this study has demonstrated,
in a subset analysis of 5 cases with 10 blinded observers,
that any differences in the distribution of dose when plan-
ning using TES contours are largely comparable withmanual dosimetric variability between observers. More-
over, this variability only considered a single institution
and may be even greater between experts at different insti-
tutions because of diversity in training backgrounds and
treatment strategies.
We observed that poor image quality could in some cases
lead to unsatisfactory results. However, the algorithm is
guided by the manually selected initial midgland boundary
points and the positions of the base and apex from which
initial contours and surfaces are produced. Because the edge
detection is performed within a certain limit of these initial
contours and surfaces, artifacts inside the prostate such as
calcifications should not pose a problem and, as long as the
image quality at midgland is adequate for the observer to
perform initialization, our method should provide consistent
results.
Our program regards the reproducibility of the align-
ment between the prostate, the probe and the patient’s cra-
niocaudal axes to be important, as the accurate registration
of the preplanned PTV with the prostate as visualized on
the day of the implant to be a vital component in streamlin-
ing the procedure and reducing setup complications. This is
facilitated by ensuring that the prostate is positioned so as
to have midsagittal symmetry in the planning images. In
addition, a smooth CTV topography is preferred to reduce
the sensitivity of coverage to misalignment. The TES algo-
rithm achieves these two goals with a minimum of operator
assistance.
In our experience, the algorithm greatly reduces the time
necessary to arrive at an acceptable CTV. The initialization
of the algorithm and generation of a smooth and symmetric
3D surface, which is tedious to accomplish by hand,
requires less than a minute by a radiation therapist. Once
this (the Raw TES) CTV is complete, only 2e4 min of
review and modification are required by the RO to arrive
at what we have described as the RO-reviewed TES CTV,
which is currently used for planning.
The results of this study suggest that many of the modi-
fications to the Raw TES PTVs before planning are super-
fluous, in the sense that the impact of not performing the
modifications will result in a planned dose distribution
not dissimilar in quality to that which would have been
delivered if the patient had been treated by a colleague.
On the basis of this finding, we conclude that the proposed
TES algorithm is a suitable replacement for manual pros-
tate segmentation in a preplanned treatment methodology.Acknowledgments
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